Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
European Radiology|June 29, 2019
Comparison of analgesic techniques in MRI-guided in-bore prostate biopsyM Quentin, C Arsov, T Ullrich, et al.
European Journal of Radiology|September 22, 2014
Predictive power of the ESUR scoring system for prostate cancer diagnosis verified with targeted MR-guided in-bore biopsyL Schimmöller, M Quentin, C Arsov, et al.
European Radiology|June 13, 2013
Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standardL Schimmöller, M Quentin, C Arsov, et al.
Magnetic Resonance Imaging|April 27, 2021
Arterial spin labelling as a gadolinium-free alternative in the detection of prostate cancerM Boschheidgen, L Schimmöller, L Kasprowski, et al.
European Journal of Radiology|July 11, 2020
Advanced diffusion weighted imaging of the prostate: Comparison of readout-segmented multi-shot, parallel-transmit and single-shot echo-planar imagingM Klingebiel, T Ullrich, M Quentin, et al.
European Journal of Radiology|September 19, 2021
Comparison and prediction of artefact severity due to total hip replacement in 1.5 T versus 3 T MRI of the prostateM Boschheidgen, T Ullrich, D Blondin, et al.
European Journal of Radiology|September 18, 2022
Impact of dynamic contrast-enhanced MRI in 1.5 T versus 3 T MRI for clinically significant prostate cancer detectionF Ziayee, L Schimmöller, D Blondin, et al.
European Radiology|June 28, 2020
Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort studyT Ullrich, C Arsov, M Quentin, et al.
European Radiology|July 9, 2017
Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostateT Ullrich, M Quentin, A K Schmaltz, et al.
Urologia Internationalis|June 9, 2012
Evaluation of a structured report of functional prostate magnetic resonance imaging in patients with suspicion for prostate cancer or under active surveillanceM Quentin, D Blondin, J Klasen, et al.
Pageof 4